The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Vanda Pharmaceuticals Inc shares valued at $50,150 were purchased by Polymeropoulos Mihael Hristos on Mar 06 ’25. At $5.01 per share, Polymeropoulos Mihael Hristos acquired 10,000 shares. The insider’s holdings grew to 2,295,731 shares worth approximately $11.27 million following the completion of this transaction.
Also, Polymeropoulos Mihael Hristos purchased 10,000 shares, netting a total of over 50,200 in proceeds. Following the buying of shares at $5.02 each, the insider now holds 2,285,731 shares.
Before that, Polymeropoulos Mihael Hristos had added 10,000 shares to its account. In a trade valued at $47,050, the President and CEO bought Vanda Pharmaceuticals Inc shares for $4.71 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $11.17 million.
As published in their initiating research note from H.C. Wainwright on October 31, 2024, Vanda Pharmaceuticals Inc [VNDA] has been a Buy and the price target has been revised to $18. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid July. As of February 25, 2022, Jefferies has decreased its “Buy” rating to a “Hold” for VNDA. Earlier on May 12, 2021, BofA Securities initiated its rating. Their recommendation was “a Buy” for VNDA stock.
Analyzing VNDA Stock Performance
During the last five days, there has been a surge of approximately 4.47%. Over the course of the year, Vanda Pharmaceuticals Inc shares have jumped approximately 2.51%. Shares of the company reached a 52-week high of $5.19 on 03/06/25 and a 52-week low of $4.20 on 02/14/25. A 50-day SMA is recorded $4.62, while a 200-day SMA reached $5.06.
Support And Resistance Levels for Vanda Pharmaceuticals Inc (VNDA)
According to the 24-hour chart, there is a support level at 4.80, which, if violated, would cause prices to drop to 4.70. In the upper region, resistance lies at 5.10. The next price resistance is at 5.30. RSI (Relative Strength Index) is 58.30 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.31, which suggests the price will decrease in the coming days. Percent R is at 28.28%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
